Institutional Fund
Mpm Bioimpact LLC
Boston, MACIK 16870785 filings on record
Portfolio Value
$1.29B
Q1 2026
Holdings
41
Reported positions
New Buys
11
Opened this quarter
QoQ Change
+48.2%
from $873.95M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Dbv Technologies S A8.4%
- Cullinan Therapeutics Inc8.4%
- Aktis Oncology Inc6.7%
- Liquidia Corporation4.1%
- Alumis Inc4.1%
- Edgewise Therapeutics Inc4.0%
- Other64.3%
Portfolio Holdings
41 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Dbv Technologies S A | 5.21M | $108.91M | 8.4% | +4.22M | Added |
| 2 | Cullinan Therapeutics Inc | 7.65M | $108.68M | 8.4% | 0 | Held |
| 3 | Aktis Oncology Inc | 4.84M | $86.51M | 6.7% | +4.84M | New |
| 4 | Liquidia Corporation | 1.41M | $53.03M | 4.1% | +4.3K | Added |
| 5 | Alumis Inc | 2.39M | $52.58M | 4.1% | −15.5K | Reduced |
| 6 | Edgewise Therapeutics Inc | 1.66M | $52.31M | 4.0% | +5.4K | Added |
| 7 | Revolution Medicines Inc | 506.8K | $49.28M | 3.8% | +1.1K | Added |
| 8 | Agios Pharmaceuticals Inc | 1.31M | $44.19M | 3.4% | +2.9K | Added |
| 9 | Corcept Therapeutics Inc | 985.7K | $39.73M | 3.1% | +985.7K | New |
| 10 | Trevi Therapeutics Inc | 3.30M | $39.35M | 3.0% | +11.3K | Added |
31 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio